By Maddie Sorenson Integra Lifesciences Holdings Corp (NASDAQ:IART) was upgraded by Zacks from a “sell” rating to a “hold” rating in a research note issued on Monday, ARN reports. According to Zacks, “We are impressed with Integra’s second-quarter 2015 results which squarely beat the Zacks Consensus Estimate.